<p>Kaplan–Meier estimates of overall survival between patients with locoregional recurrence and those with distant recurrence.</p
<p>Kaplan-Meier estimates of 3-years probability of recurrence free survival after first admission, ...
<p>Kaplan-Meier curves for locoregional recurrence free survival (LRRFS) according to the luminal su...
<p>Kaplan-Meier curves for locoregional recurrence free survival (LRRFS) according to the pathologic...
Kaplan–Meier estimates of overall survival in patients with and without sarcopenia.</p
<p>Kaplan–Meier estimates of overall survival according to the locoregional SUV<sub>max</sub> or the...
<p>Kaplan–Meier estimates of overall survival according to the distant SUV<sub>max</sub> or the plas...
<p>(a) overall survival; (b) locoregional relapse-free survival; (c) distant metastasis-free surviva...
<p>Kaplan-Meier estimates of recurrence-free survival (left) and ocular survival (right) by route of...
<p>The cause-specific survival (A) and overall survival (B) of individual R classification for pN1 p...
<p>Kaplan-Meier estimates of disease-free survival (A), relapse-free survival (B), and overall survi...
<p>Kaplan-Meier estimates of (a) overall survival, (b) distant progression-free survival and (c) loc...
<p>Kaplan-Meier estimates of Overral survival and disease-free survival for patients receiving with ...
<p>The graphs show recurrence-free survival (A) and overall survival (B) according to the recurrence...
<p>(A) OS in the entire cohort (n = 104) at 2 years was 87.3% (95% CI, 80.5–94.1%) and 75.6% (95% CI...
Kaplan–Meier survival curve of disease-specific survival according to the N stage (A) and treatment ...
<p>Kaplan-Meier estimates of 3-years probability of recurrence free survival after first admission, ...
<p>Kaplan-Meier curves for locoregional recurrence free survival (LRRFS) according to the luminal su...
<p>Kaplan-Meier curves for locoregional recurrence free survival (LRRFS) according to the pathologic...
Kaplan–Meier estimates of overall survival in patients with and without sarcopenia.</p
<p>Kaplan–Meier estimates of overall survival according to the locoregional SUV<sub>max</sub> or the...
<p>Kaplan–Meier estimates of overall survival according to the distant SUV<sub>max</sub> or the plas...
<p>(a) overall survival; (b) locoregional relapse-free survival; (c) distant metastasis-free surviva...
<p>Kaplan-Meier estimates of recurrence-free survival (left) and ocular survival (right) by route of...
<p>The cause-specific survival (A) and overall survival (B) of individual R classification for pN1 p...
<p>Kaplan-Meier estimates of disease-free survival (A), relapse-free survival (B), and overall survi...
<p>Kaplan-Meier estimates of (a) overall survival, (b) distant progression-free survival and (c) loc...
<p>Kaplan-Meier estimates of Overral survival and disease-free survival for patients receiving with ...
<p>The graphs show recurrence-free survival (A) and overall survival (B) according to the recurrence...
<p>(A) OS in the entire cohort (n = 104) at 2 years was 87.3% (95% CI, 80.5–94.1%) and 75.6% (95% CI...
Kaplan–Meier survival curve of disease-specific survival according to the N stage (A) and treatment ...
<p>Kaplan-Meier estimates of 3-years probability of recurrence free survival after first admission, ...
<p>Kaplan-Meier curves for locoregional recurrence free survival (LRRFS) according to the luminal su...
<p>Kaplan-Meier curves for locoregional recurrence free survival (LRRFS) according to the pathologic...